RaySearch Laboratories AB (publ) (STO:RAY.B)

RaySearch Laboratories AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	158.3	407.3	462.7	343.68	160.27	102.54
Cash & Short-Term Investments	158.3	407.3	462.7	343.68	160.27	102.54
Cash Growth	-50.96%	-11.97%	34.63%	114.44%	56.31%	-39.24%
Accounts Receivable	559.4	473.9	444.8	383.73	370.57	317.36
Other Receivables	60.4	19.9	23.3	30.07	27.7	40.81
Receivables	619.8	493.8	468.1	413.79	398.26	358.17
Inventory	50.1	22	10.6	9.32	14.09	29.99
Prepaid Expenses	-	16.6	17.1	12.36	37.47	20.13
Other Current Assets	-	31	26.2	23.29	17.83	5.55
Total Current Assets	828.2	970.7	984.7	802.45	627.92	516.37
Property, Plant & Equipment	390.9	447.3	526.7	590.42	649.07	666.54
Other Intangible Assets	586.2	558.7	548.2	530.46	518.66	523.11
Long-Term Accounts Receivable	-	0.9	20.9	22.2	54.33	10
Long-Term Deferred Tax Assets	9.6	8.4	3.9	5.73	25.6	28.53
Other Long-Term Assets	3.9	6	6.8	1.43	0.36	0.21
Total Assets	1,819	1,992	2,091	1,953	1,876	1,745

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	29.9	35.4	38.8	42.09	24.03	48.77
Accrued Expenses	-	65.2	57.5	41.72	50.71	44.9
Current Portion of Long-Term Debt	-	-	-	-	-	21.27
Current Portion of Leases	78	77.5	77.1	97.38	81.31	49.11
Current Income Taxes Payable	-	15.5	42.2	5.49	4.98	3.71
Current Unearned Revenue	359.2	355.9	454.2	461.14	460.71	341.01
Other Current Liabilities	94.7	20.4	34	27.24	15.36	7.98
Total Current Liabilities	627.7	569.9	703.8	675.05	637.1	516.75
Long-Term Leases	262.1	317.3	394.9	431.98	474.08	491.02
Long-Term Deferred Tax Liabilities	123.4	118.6	114.9	109.53	106.87	107.78
Other Long-Term Liabilities	0.8	0.9	0.9	0.88	0.74	0.88
Total Liabilities	1,014	1,007	1,215	1,217	1,219	1,116

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	804.8	17.1	17.1	17.14	17.14	17.14
Additional Paid-In Capital	-	2	2	1.98	1.98	1.98
Retained Earnings	-	982	856.9	721.98	640.41	616.63
Comprehensive Income & Other	-	-15.8	0.7	-5.87	-2.37	-7.44
Shareholders' Equity	804.8	985.3	876.7	735.23	657.16	628.31
Total Liabilities & Equity	1,819	1,992	2,091	1,953	1,876	1,745

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	406	394.8	472	529.36	555.39	561.4
Net Cash (Debt)	-247.7	12.5	-9.3	-185.68	-395.12	-458.86
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.28	0.36	-0.27	-5.42	-11.53	-13.38
Filing Date Shares Outstanding	33.29	34.28	34.28	34.28	34.28	34.28
Total Common Shares Outstanding	33.29	34.28	34.28	34.28	34.28	34.28
Working Capital	200.5	400.8	280.9	127.4	-9.18	-0.39
Book Value Per Share	24.18	28.74	25.57	21.45	19.17	18.33
Tangible Book Value	218.6	426.6	328.5	204.78	138.49	105.2
Tangible Book Value Per Share	6.57	12.44	9.58	5.97	4.04	3.07
Machinery	-	281.5	284.7	262.43	243.37	224.37
Order Backlog	-	1,528	1,813	1,864	1,940	1,363

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error